Cargando…
Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing
The coronavirus pandemic (COVID-19) has had an unprecedented effect on various disease processes and their management. COVID-19 is likely to have a complex pathophysiological interplay with the post-transplant patients; one affecting the clinical course and outcome of the other. In the absence of va...
Autor principal: | Rammohan, Ashwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504191/ https://www.ncbi.nlm.nih.gov/pubmed/32995321 http://dx.doi.org/10.5500/wjt.v10.i9.267 |
Ejemplares similares
-
Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection
por: Vij, Mukul, et al.
Publicado: (2022) -
Post-COVID-19 cholangiopathy: Current understanding and management options
por: Veerankutty, Fadl H, et al.
Publicado: (2023) -
Current perspectives on the role of liver transplantation for Langerhans cell histiocytosis: A narrative review
por: Menon, Jagadeesh, et al.
Publicado: (2022) -
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
por: Shariq, Mohd, et al.
Publicado: (2022) -
Robotic donor hepatectomy: Are we there yet?
por: Rammohan, Ashwin, et al.
Publicado: (2021)